An Update on Triptorelin: Current Thinking on Androgen Deprivation Therapy for Prostate Cancer

Androgen deprivation therapy (ADT) is the mainstay palliative treatment for men with locally advanced and metastatic prostate cancer, and aims to reduce testosterone to levels obtained by surgical castration. Use of gonadotropin-releasing hormone (GnRH) agonists predominates among the ADT options. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Merseburger, Axel S., Hupe, Marie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939158/
https://www.ncbi.nlm.nih.gov/pubmed/27246172
http://dx.doi.org/10.1007/s12325-016-0351-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939158/
https://www.ncbi.nlm.nih.gov/pubmed/27246172
http://dx.doi.org/10.1007/s12325-016-0351-4

Ejemplares similares